Chronic rhinosinusitis (CRS) comprises heterogeneous eosinophilic (type-2) and neutrophilic (type-1/3) endotypes, yet existing murine models rarely distinguish them or compare their therapeutic responsiveness.
Methods
Seven-week-old female C57BL/6N mice received intranasal instillations three times weekly for 4 or 12 weeks with either (1) a clinically relevant airborne allergen cocktail (house dust mite [HDM], Aspergillus fumigatus, Alternaria alternata, and Staphylococcus aureus protease) to induce eosinophilic CRS (ECRS) or (2) an innate stimulus mixture (lipopolysaccharide, β-1,3-glucan, and S. aureus protease) to induce neutrophilic CRS (NCRS). A parallel cohort received weekly dexamethasone administration (2 mg/kg). Endpoints included flow cytometry, enzyme-linked immunosorbent assays, quantitative PCR, histology, and immunofluorescence assays.
Results
Four-week allergen exposure produced a pure ECRS phenotype characterized by robust tissue eosinophilia, type-2 cytokines, and marked responsiveness to dexamethasone. Extending allergen delivery to 12 weeks generated mixed CRS with superimposed neutrophilia, upregulation of Il1b/Tgfb1, mucus hypersecretion, and attenuated steroid efficacy. Innate stimulus treatment yielded a steroid-resistant NCRS phenotype dominated by neutrophils, elevated Ifng/Il17a expression, and minimal type-2 biomarkers. Systemic eotaxin and HDM-specific immunoglobulin E mirrored those found in local eosinophilia, whereas circulating granulocytes remained unchanged across groups.
Conclusions
By adjusting the stimulus type and duration, we established tunable murine models that recapitulate pure ECRS, mixed CRS, and steroid-resistant NCRS within a single genetic background. These paired models provide a versatile platform for dissecting endotype-specific mechanisms and evaluating tailored interventions, highlighting the potential importance of early, phenotype-directed CRS therapy.
KatoASchleimerRPBleierBS. Mechanisms and pathogenesis of chronic rhinosinusitis. J Allergy Clin Immunol. 2022;149(5):1491–1503. Doi: 10.1016/J.JACI.2022.02.016
2.
KandaAKondoKHosakaN, et al.Eosinophilic upper airway inflammation in a murine model using an adoptive transfer system induces hyposmia and epithelial layer injury with convex lesions. Med Sci. 2019;7(2):22. Doi: 10.3390/medsci7020022
3.
YeXBaoQChenH, et al.Type 2 and type 17 invariant natural killer T cells contribute to local eosinophilic and neutrophilic inflammation and their function is regulated by mucosal microenvironment in nasal polyps. Front Immunol. 2022;13:803097. Doi: 10.3389/fimmu.2022.803097
4.
SaitoTOkazakiKFushimiKTsuzukiK. Usefulness of post-operative endoscopic score for optimal treatment selection in recurrent eosinophilic chronic rhinosinusitis. J Laryngol Otol. 2024;138(2):162–168. Doi: 10.1017/S0022215123000798
5.
ChungJImSYParkSK, et al.Inotodiol attenuates mucosal inflammation in a mouse model of eosinophilic chronic rhinosinusitis. Allergy Asthma Immunol Res. 2024;17(1):77–93. Doi: 10.4168/aair.2025.17.1.77
6.
HamourAFLeeJJWWasilewskiE, et al.Murine model for chronic rhinosinusitis: An interventional study. J Otolaryngol - Head Neck Surg. 2023;52:32. Doi: 10.1186/s40463-023-00637-6
7.
LiYHePYanB, et al.Induction of a type 2 inflammatory chronic rhinosinusitis in C57BL/6 mice. Asia Pac Allergy. 2023;13(4):164–174. Doi: 10.5415/apallergy.0000000000000123
8.
LindsayRSlaughterTBritton-WebbJ, et al.Development of a murine model of chronic rhinosinusitis. Otolaryngol–Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2006;134(5):724–730. discussion 731-732. Doi: 10.1016/j.otohns.2005.11.048.
9.
KimDWKhalmuratovaRGu HurD, et al.Staphylococcus Aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model. Am J Rhinol Allergy. 2011;25(6):e255–e261. Doi: 10.2500/ajra.2011.25.3727
10.
ChangDYJooYHKimSJ, et al.Therapeutic effects of intranasal cyclosporine for eosinophilic rhinosinusitis with nasal polyps in a mouse model. Am J Rhinol Allergy. 2015;29(1):e29–e32. Doi: 10.2500/ajra.2015.29.4152
11.
ShinHW. Animal models in CRS and pathophysiologic insights gained: A systematic review. Laryngoscope Investig Otolaryngol. 2016;1(5):116–123. Doi: 10.1002/lio2.29
LeinoMSLoxhamMBlumeC, et al.Barrier disrupting effects of alternaria alternata extract on bronchial epithelium from asthmatic donors. PloS One. 2013;8(8):e71278. Doi: 10.1371/journal.pone.0071278
19.
TeufelbergerARNordengrünMBraunH, et al.The IL-33/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus-derived serine protease-like protein D. J Allergy Clin Immunol. 2018;141(2):549–559.e7. Doi: 10.1016/j.jaci.2017.05.004
20.
JordeISchreiberJStegemann-KoniszewskiS. The role of Staphylococcus aureus and its toxins in the pathogenesis of allergic asthma. Int J Mol Sci. 2023;24(1):654. Doi: 10.3390/ijms24010654
21.
WangSZhangHXiZ, et al.Establishment of a mouse model of lipopolysaccharide-induced neutrophilic nasal polyps. Exp Ther Med. 2017;14(6):5275–5282. Doi: 10.3892/etm.2017.5208
22.
KomakiSImaiRSugimotoY, et al.Acute and chronic nasal inflammation induces lymphangiogenesis in the olfactory mucosa in mice. Brain Behav Immun - Health. 2025;49:101119. Doi: 10.1016/j.bbih.2025.101119
23.
HadebeSKirsteinFFierensK, et al.β-Glucan exacerbates allergic airway responses to house dust mite allergen. Respir Res. 2016;17(1):35. Doi: 10.1186/s12931-016-0352-5
24.
RyuJHYooJYKimMJ, et al.Distinct TLR-mediated pathways regulate house dust mite-induced allergic disease in the upper and lower airways. J Allergy Clin Immunol. 2013;131(2):549–561. Doi: 10.1016/j.jaci.2012.07.050
25.
LinJYChenJSChenPC, et al.Concurrent exposure to a dectin-1 agonist suppresses the Th2 response to epicutaneously introduced antigen in mice. J Biomed Sci. 2013;20(1):1. Doi: 10.1186/1423-0127-20-1
26.
LuoQZhangZLiuDFengKJinXZhangJ. Human neutrophil elastase induces MUC5AC overexpression in chronic rhinosinusitis through tumour necrosis factor-α converting enzyme. Acta Otolaryngol (Stockh). 2016;136(6):641–648. Doi: 10.3109/00016489.2016.1144145
27.
XiaWBaiJWuX, et al.Interleukin-17A promotes MUC5AC expression and goblet cell hyperplasia in nasal polyps via the Act1-mediated pathway. PLOS ONE. 2014;9(6):e98915. Doi: 10.1371/journal.pone.0098915
28.
FujisawaTVelichkoSThaiPHungLYHuangFWuR. Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm. J Immunol Baltim Md. 2009;183(10):6236–6243. 1950. Doi: 10.4049/jimmunol.0900614.
29.
KimHCLimJYKimSKimJHJangYJ. Development of a mouse model of eosinophilic chronic rhinosinusitis with nasal polyp by nasal instillation of an Aspergillus protease and ovalbumin. Eur Arch Otorhinolaryngol. 2017;274(11):3899–3906. Doi: 10.1007/s00405-017-4717-2.
30.
MendiolaMTharakanAChenMAsempaTLaneAPRamanathanM. Characterization of a novel high dose ovalbumin induced murine model of allergic sinonasal inflammation. Int Forum Allergy Rhinol. 2016;6(9):964–972. Doi: 10.1002/alr.21768
31.
HydeEJWakelinKADanielsNJGhoshSRoncheseF. Similar immune mechanisms control experimental airway eosinophilia elicited by different allergens and treatment protocols. BMC Immunol. 2019;20(1):18. Doi: 10.1186/s12865-019-0295-y
32.
LeeKZhangIKymanSKaskOCopeEK. Co-infection of malassezia sympodialis with bacterial pathobionts Pseudomonas aeruginosa or Staphylococcus aureus leads to distinct sinonasal inflammatory responses in a murine acute sinusitis model. Front Cell Infect Microbiol. 2020;10:472. Doi: 10.3389/fcimb.2020.00472
33.
AlfordMAChoiKYGTrimbleMJ, et al.Murine model of sinusitis infection for screening antimicrobial and immunomodulatory therapies. Front Cell Infect Microbiol. 2021;11:621081. Doi: 10.3389/fcimb.2021.621081
34.
SunHDamaniaAMairML, et al.STAT6 blockade abrogates Aspergillus-induced eosinophilic chronic rhinosinusitis and asthma, A model of unified airway disease. Front Immunol. 2022;13:818017. Doi: 10.3389/fimmu.2022.818017
35.
NishioTWakaharaKSuzukiY, et al.Mixed cell type in airway inflammation is the dominant phenotype in asthma patients with severe chronic rhinosinusitis. Allergol Int Off J Jpn Soc Allergol. 2019;68(4):515–520. Doi: 10.1016/j.alit.2019.05.004
36.
ElderMJWebsterSJCheeRWilliamsDLHill GastonJSGoodallJC. β-glucan size controls dectin-1-mediated immune responses in human dendritic cells by regulating IL-1β production. Front Immunol. 2017;8:791. Doi: 10.3389/fimmu.2017.00791
37.
WynneMAtkinsonCSchlosserRJMulliganJK. Contribution of epithelial cell dysfunction to the pathogenesis of chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2019;33(6):782. Doi: 10.1177/1945892419868588
38.
XieXWangPJinM, et al.IL-1β-induced epithelial cell and fibroblast transdifferentiation promotes neutrophil recruitment in chronic rhinosinusitis with nasal polyps. Nat Commun. 2024;15(1):9101. Doi: 10.1038/s41467-024-53307-0
BesnardAGTogbeDCouillinI, et al.Inflammasome-IL-1-Th17 response in allergic lung inflammation. J Mol Cell Biol. 2012;4(1):3–10. Doi: 10.1093/jmcb/mjr042
41.
IkedaSSaijoSMurayamaMAShimizuKAkitsuAIwakuraY. Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-β-induced Foxp3 expression. J Immunol Baltim Md. 2014;192(4):1449–1458. 1950. Doi: 10.4049/jimmunol.1300387.
42.
Calvo-HenriquezCViera-ArtilesJRodriguez-IglesiasM, et al.The role of corticosteroid nasal irrigations in the management of chronic rhinosinusitis: A state-of-the-art systematic review. J Clin Med. 2023;12(10):3605. Doi: 10.3390/jcm12103605
43.
ChenLFanXYangLHanLWangNBianK. Research progress of glucocorticoid resistance in chronic rhinosinusitis with nasal polyps: A review. Medicine (Baltimore). 2023;102(46):e36024. Doi: 10.1097/MD.0000000000036024
44.
KimDKKimJYHanYE, et al.Elastase-positive neutrophils are associated with refractoriness of chronic rhinosinusitis with nasal polyps in an Asian population. Allergy Asthma Immunol Res. 2019;12(1):42–55. Doi: 10.4168/aair.2020.12.1.42
45.
WangHPanLLiuZ. Neutrophils as a protagonist and target in chronic rhinosinusitis. Clin Exp Otorhinolaryngol. 2019;12(4):337–347. Doi: 10.21053/ceo.2019.00654
46.
YehCFHuangWHLanMYHungW. Lipopolysaccharide-Initiated rhinosinusitis causes neuroinflammation and olfactory dysfunction in mice. Am J Rhinol Allergy. 2023;37(3):298–306. Doi: 10.1177/19458924221140965
47.
ChenYSFengCYSuSHWangYHYangTHLinCF. Recurrence of chronic rhinosinusitis with nasal polyps after surgery: Risk factors, predictive models, and treatment approaches with a focus on western and Asian differences. Med Kaunas Lith. 2025;61(9):1620. Doi: 10.3390/medicina61091620
48.
SongYChoSW. Biomarkers in chronic rhinosinusitis with nasal polyp: Personalized medicine based on endotype. Korean J Otorhinolaryngol-Head Neck Surg. 2019;62(8):427–434. Doi: 10.3342/kjorl-hns.2019.00332
49.
ZhangYGevaertELouH, et al.Chronic rhinosinusitis in Asia. J Allergy Clin Immunol. 2017;140(5):1230–1239. Doi: 10.1016/j.jaci.2017.09.009
50.
KimDWEunKMRohEYShinSKimDK. Chronic rhinosinusitis without nasal polyps in Asian patients shows mixed inflammatory patterns and neutrophil-related disease severity. Mediators Inflamm. 2019;2019:7138643. Doi: 10.1155/2019/7138643
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
